専門領域の医師向けの論文紹介podcastです。 放射線科の放射線治療・放射線腫瘍学に関連する新着論文を厳選し、毎日10本程度紹介します。 GPT4-APIを利用して日本語要約し、AI音声で読み上げます。 メール配信がメインのサービスです。配信登録は医師限定ですが、興味があれば下記をごらんください。 https://489.ai/
Language
🇯🇵
Publishing Since
9/12/2023
Email Addresses
1 available
Phone Numbers
0 available
November 21, 2024
Radiation oncology expert Dr. Takashi Nakano summarizes the latest research papers of November 22nd, empowering healthcare professionals with timely insights and AI-driven analysis.
November 20, 2024
Leading radiation oncologists discuss the latest AI-summaries of groundbreaking research, empowering medical professionals to stay at the forefront of cutting-edge treatments and advancements.
November 18, 2024
11月19日の放射線腫瘍学に関連する新着論文紹介です。専門医取得済みの医師を想定して作成しています。 メール配信がメインのサービスです。メール配信登録は医師限定ですが、興味があれば下記をごらんください。 <a href="https://489.ai/">https://489.ai/</a>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.